The key to czd to me is that it is a platform technology, meaning it can be used in anything from wounds, deep burns, plastic surgery, etc etc. the fact also there are well documented issues with the mkt leader re tnp is a big plus, plus the fact there is really no product in burns etc that surgeons have any real faith in? So in summary, we are likely talking a simple FDA approved product, that has the ability to becoming a very commonly used product?
And no need to raise capital.
Terrible news for shareholders,...just terrible
CZD Price at posting:
11.5¢ Sentiment: None Disclosure: Held
